BIOS Actuate Co-Invest I, LP bought $500K of Actuate Therapeutics (ACTU)

Executed Jun 27 2025, disclosed Jun 30 2025, 3 days later.

Value, as filed

$500K

71,428 sh × $7.00

Executed

Jun 27 2025

the trade date, as filed

Disclosed

Jun 30 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+15.1%

+5.5% from execution

Over the 21 trading sessions from the disclosed entry session (Jun 30 2025), the stock returned +15.1% (delay-adjusted); from the execution session (Jun 27 2025), +5.5%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

BL BIOS Actuate Co-Invest I, LP Director profile →

BIOS Actuate Co-Invest I, LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in ACTU. Across 1 priced purchase filing, the average 21-session return was +5.5% from execution and +15.1% from disclosure (delay-adjusted; derived). The largest single filing was $500K of ACTU (71,428 sh × $7.00, as filed), executed Jun 27 2025.

The name

ACTU ACTU ACTU · 4 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→